glp 1 agonist comparison of agonists Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review comparison of glp 1 agonists

Daniel Drucker [Biomarker April 2023] To date, the adverse event profile of GLP-1R agonists is characterized by relatively mild gastrointestinal (GI) side effects, such as nausea, vomiting, and diarrhea

No dose adjustments are recommended for patients with renal impairment

Because weight-loss medications like Ozempic or Wegovy dramatically slow down your digestive system, adding this heavy mass creates a literal logjam

Few include direct skeletal muscle measures

Thus, professional reviewers highlight the need for ongoing surveillance of bone health, neurodevelopment, and metabolic effects over years (37, 38)

Sun Y, Liang Y, Li Z, Xia N